Glaxo stumbles in race for new kind of AIDS drug
19th Sep 2005, 10:28 GMT
LONDON (Reuters) - GlaxoSmithKline Plc has suffered a setback in the race to develop a new kind of AIDS pill, following two cases of serious liver problems in patients taking its experimental drug aplaviroc.
Latest news from Reuters: Health:
- Roche flu drug to carry new caution in U.S.
- Gene chip test identifies bird flu strains
- Bristol arthritis drug effective in children: study
- World's poor still deprived of drugs: activists
- Study questions radiation after prostate removal
- Chocolate addiction leads to sweet discovery
- Researchers spur growth of adult brain stem cells
- Angioplasty no help for heart attack victims who wait
- Diabetics fare better with drug-eluting stents
- Very obese fare worse after colon cancer diagnosis